Heptabarb (INN; Eudan, Medapan, Medomin, Noctyn), also known as heptabarbitone (BAN) or heptabarbital, is a sedative and hypnotic drug of the barbiturate family.[2][3] It was used in Europe for the treatment of insomnia from the 1950s onwards, but has since been discontinued.[2][3]
Clinical data | |
---|---|
Other names | G-475 |
Routes of administration | Oral[1] |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 83%[1] |
Metabolism | Hepatic |
Elimination half-life | 6.1-11.2 hours[1] |
Excretion | Renal[1] |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.007.371 |
Chemical and physical data | |
Formula | C13H18N2O3 |
Molar mass | 250.298 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |